ClinicalTrials.gg
RecruitingNCT05540548APLOMBUpdated Aug 24, 2025

Contribution of the Podiatrist-Posturologist in the Evaluation of the Link Between the Stabilometric Parameters and the Pain Felt in Patients With Chronic Low Back Pain

An observational study in Chronic Low Back Pain, sponsored by University Hospital, Lille. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-24.

Sponsored by University Hospital, Lille · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
139
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 11 studies in Kinesiophobia with a site in France — 4 open to participants now, 5 under way, none of them phase 3. Kinesiophobia · France.

Started
2024
with 1 other
Observational
3 of 11
1 open now
Registered
4th of 11
by date
Lead sponsor
1 of 11
University Hospital, Lille

Among the 11 studies in Kinesiophobia with a site in France, this one is one of 2 that started in 2024, is one of 3 observational ones, and was the 4th registered.

Kinesiophobia

287 studies on the registry are indexed under Kinesiophobia; 92 are open to participants now.

Browse Kinesiophobia studies →

Open to participants now

4 of the 11 studies in Kinesiophobia with a site in France are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 43 Kinesiophobia studies recruiting now, 13 (30%) set no upper age limit and 24 (56%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Kinesiophobia with a site in France, or all of them as a file.
02

Study summary

Chronic low back pain is one of the major causes of disability worldwide. Knowledge about the pathophysiology of low back pain is insufficient, and an accurate diagnosis can only be obtained in 10 to 15% of cases. The absence of a precise diagnosis leads to a therapeutic challenge due to the large number of treatments available, the overall efficacy of which is low to moderate. Therefore, the identification of subgroups of non-specific chronic low back pain patients is essential and will allow the optimization of therapeutic management. A detailed description of the stabilometric parameters associated with the evaluation of pain, kinematic disturbance and the degree of kinesiophobia would allow us to establish specific postural profiles, to propose a relevant clinical model and to improve the accuracy of the diagnosis of people with chronic low back pain. The objectives of this research project are to evaluate the relationship between stabilometric parameters and pain (main objective), lumbar kinematics, kinesiophobia, and quality of life (secondary objectives) in order to propose specific postural profiles in chronic low back pain patients.

03

Conditions studied

  • Chronic Low Back Pain

Keywords

  • Chronic low back pain
  • Kinesiophobia
  • Pain
  • Posturology
  • Stabilometry
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The patients will be recruited within the pain unit of the General Hospital of Valenciennes, within the framework of the multidisciplinary consultation of the optimized pain and dedicated to the low back pain patients, where intervene a neurosurgeon algologist and a podiatrist posturologist.

The selection of patients enrolled in the multidisciplinary pain consultation dedicated to low back pain patients will be reviewed by the Clinical Study Technician (screening) and checked by the principal investigator before the newsletter is sent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Suffering from low back pain, possibly associated with painful gluteal radiation in the form of mono or bilateral pygalgia (non-radicular) evolving for at least three months (chronic low back pain
  • Understanding and being able to express himself in French
  • Giving informed, dated and signed consent

Exclusion criteria

Exclusion Criteria:

  • Neurosurgical criteria: (i) presence of clinical signs of compression and/or single or multi-root pain (Lumbosciatica with or without deficit signs, intermittent claudication of the cauda equina roots with possible sphincter signs), (ii) history inflammatory arthropathy (ankylosing spondylitis, rheumatoid arthritis), and (iii) history of lumbar spine surgery.
  • Radiographic criteria: (i) presence on the lumbar MRI of multi-level discopathy (more than 2 discopathy), (ii) spinal instability confirmed by CT or MRI (degenerative spondylolisthesis or by isthmic lysis).
  • Pregnant or breastfeeding women
  • Visually impaired patient
  • Patient suffering from neurological and/or orthopedic disorders that may affect balance.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
139 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Correlation between the average speed of displacement of the center of pressure measured in the open-eyes position and the level of pain felt in patients suffering from chronic low back pain

    Time frame: Baseline

Secondary outcomes

  1. Correlation between the other stabilometric parameters (mean surface, mean frontal and sagittal position) of postural stability measured in the open-eyes position and the level of pain felt.

    Time frame: Baseline

  2. Correlation between the stabilometric parameters (mean speed, mean surface, mean frontal and sagittal position) of postural stability (measured in the open-eyes position and in the closed-eyes position) and neuropathic pain

    Time frame: Baseline

  3. Correlation of stabilometric parameters (mean speed, mean surface, mean frontal and sagittal position) of postural stability (measured in open-eyes and closed-eyes position) with the degree of kinesiophobia and quality of life.

    Time frame: Baseline

  4. Reproducibility of the stabilometric measurements (average speed, average surface, average frontal and sagittal position) in each of the conditions (in the open-eyes position and in the closed-eyes position).

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Service de neurologie CH de Valenciennes
    Valenciennes, 59300, France
    Recruiting
    • Annarita Mora · Contact
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Jun 2026, 24 months after the start.

Of 45 non-industry observational studies under Kinesiophobia, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 24 months is above that.

Counting every sponsor, half of 45 studies reached it within 8 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 12, 2022
First posted
Sep 14, 2022
StartActual
Jun 11, 2024
Primary completionEst.
Jun 11, 2026
CompletionEst.
Jun 11, 2026
Last update
Aug 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05540548
Responsible party
Sponsor
First posted
Sep 14, 2022
Start date
Jun 11, 2024
Primary completion
Jun 11, 2026 (estimated)
Completion
Jun 11, 2026 (estimated)
Last update
Aug 24, 2025

Study contacts

Frédéric VISEUX
Contact
viseux-f@ch-valenciennes.fr
03 27 14 04 54 ext. +33
Frédéric VISEUX
principal investigator · University Hospital, Lille

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion